These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14750238)

  • 1. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.
    Bilalovic N; Blystad AK; Golouh R; Nesland JM; Selak I; Trinh D; Torlakovic E
    Am J Clin Pathol; 2004 Jan; 121(1):34-42. PubMed ID: 14750238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of PU.1 in follicular lymphoma.
    Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
    J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
    Pedersen LM; Jürgensen GW; Johnsen HE
    Br J Haematol; 2005 Mar; 128(6):813-9. PubMed ID: 15755285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
    Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
    Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5+ follicular lymphoma: a clinicopathologic study of three cases.
    Barry TS; Jaffe ES; Kingma DW; Martin AW; Sorbara L; Raffeld M; Pittaluga S
    Am J Clin Pathol; 2002 Oct; 118(4):589-98. PubMed ID: 12375647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
    Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
    Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
    Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
    Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.
    Biasoli I; Morais JC; Scheliga A; Milito CB; Romano S; Land M; Pulcheri W; Spector N
    Histopathology; 2005 Mar; 46(3):328-33. PubMed ID: 15720419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
    Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
    J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas.
    Eshoa C; Perkins S; Kampalath B; Shidham V; Juckett M; Chang CC
    Am J Clin Pathol; 2001 Jun; 115(6):862-7. PubMed ID: 11392883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.
    Wahlin BE; Sander B; Christensson B; Kimby E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):388-97. PubMed ID: 17255259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD23 expression in follicular lymphoma: clinicopathologic correlations.
    Olteanu H; Fenske TS; Harrington AM; Szabo A; He P; Kroft SH
    Am J Clin Pathol; 2011 Jan; 135(1):46-53. PubMed ID: 21173123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
    Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
    Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
    Gulmann C; Espina V; Petricoin E; Longo DL; Santi M; Knutsen T; Raffeld M; Jaffe ES; Liotta LA; Feldman AL
    Clin Cancer Res; 2005 Aug; 11(16):5847-55. PubMed ID: 16115925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
    Natkunam Y; Farinha P; Hsi ED; Hans CP; Tibshirani R; Sehn LH; Connors JM; Gratzinger D; Rosado M; Zhao S; Pohlman B; Wongchaowart N; Bast M; Avigdor A; Schiby G; Nagler A; Byrne GE; Levy R; Gascoyne RD; Lossos IS
    J Clin Oncol; 2008 Jan; 26(3):447-54. PubMed ID: 18086797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular lymphoma of the duodenum: a clinicopathologic analysis of 26 cases.
    Sentani K; Maeshima AM; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Jpn J Clin Oncol; 2008 Aug; 38(8):547-52. PubMed ID: 18687756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.